Loading clinical trials...
Loading clinical trials...
An Open-label, Multi-center, Phase I Study to Evaluate the Safety/Tolerability and Pharmacokinetics of GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Conditions
Interventions
GFS202A injection
Locations
1
China
Sun-Yat Sen university cancer center
Guangzhou, Guangdong, China
Start Date
April 24, 2025
Primary Completion Date
June 8, 2026
Completion Date
July 6, 2026
Last Updated
June 5, 2025
NCT07072728
NCT07237464
NCT07033026
NCT01614990
NCT04208334
NCT04127981
Lead Sponsor
Genfleet Therapeutics (Shanghai) Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions